These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9685869)

  • 1. Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats.
    Löbenberg R; Araujo L; von Briesen H; Rodgers E; Kreuter J
    J Control Release; 1998 Jan; 50(1-3):21-30. PubMed ID: 9685869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy.
    Löbenberg R; Kreuter J
    AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1709-15. PubMed ID: 8959248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.
    Löbenberg R; Maas J; Kreuter J
    J Drug Target; 1998; 5(3):171-9. PubMed ID: 9606007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes.
    Jin SX; Bi DZ; Wang J; Wang YZ; Hu HG; Deng YH
    Pharmazie; 2005 Nov; 60(11):840-3. PubMed ID: 16320946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of 3'-azido 3'-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues.
    Dembri A; Montisci MJ; Gantier JC; Chacun H; Ponchel G
    Pharm Res; 2001 Apr; 18(4):467-73. PubMed ID: 11451033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of zidovudine following intravenous bolus administration of a novel niosome preparation devoid of cholesterol.
    Gopinath D; Ravi D; Karwa R; Rao BR; Shashank A; Rambhau D
    Arzneimittelforschung; 2001 Nov; 51(11):924-30. PubMed ID: 11765596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The distribution of azidothymidine palmitate galactosylated liposomes in mice].
    Wu HB; Deng YH; Wang SN; Zhou XY; Wang N; Shi L
    Yao Xue Xue Bao; 2007 May; 42(5):538-44. PubMed ID: 17703780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes.
    Garg M; Jain NK
    J Drug Target; 2006 Jan; 14(1):1-11. PubMed ID: 16603446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine.
    Jin Y; Qi N; Tong L; Chen D
    Int J Pharm; 2010 Feb; 386(1-2):268-74. PubMed ID: 19941945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats.
    Kumar P; Lakshmi YS; C B; Golla K; Kondapi AK
    PLoS One; 2015; 10(10):e0140399. PubMed ID: 26461917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced delivery of AZT to macrophages via acetylated LDL.
    Hu J; Liu H; Wang L
    J Control Release; 2000 Dec; 69(3):327-35. PubMed ID: 11102673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a brain-targeting zidovudine chemical delivery system in dogs.
    Brewster ME; Anderson WR; Webb AI; Pablo LM; Meinsma D; Moreno D; Derendorf H; Bodor N; Pop E
    Antimicrob Agents Chemother; 1997 Jan; 41(1):122-8. PubMed ID: 8980767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats.
    Ambruosi A; Yamamoto H; Kreuter J
    J Drug Target; 2005 Dec; 13(10):535-42. PubMed ID: 16390814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.
    Dalpiaz A; Fogagnolo M; Ferraro L; Capuzzo A; Pavan B; Rassu G; Salis A; Giunchedi P; Gavini E
    Antiviral Res; 2015 Nov; 123():146-57. PubMed ID: 26427553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.
    Dalpiaz A; Fogagnolo M; Ferraro L; Beggiato S; Hanuskova M; Maretti E; Sacchetti F; Leo E; Pavan B
    Eur J Pharm Biopharm; 2019 Nov; 144():91-100. PubMed ID: 31521715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplacental pharmacokinetics and fetal distribution of azidothymidine, its glucuronide, and phosphorylated metabolites in late-term rhesus macaques after maternal infusion.
    Patterson TA; Binienda ZK; Lipe GW; Gillam MP; Slikker W; Sandberg JA
    Drug Metab Dispos; 1997 Apr; 25(4):453-9. PubMed ID: 9107545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
    Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
    J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Characterization of Chitosan Nanoparticles for Zidovudine Nasal Delivery.
    Barbi Mda S; Carvalho FC; Kiill CP; Barud Hda S; Santagneli SH; Ribeiro SJ; Gremião MP
    J Nanosci Nanotechnol; 2015 Jan; 15(1):865-74. PubMed ID: 26328451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
    Quevedo MA; Briñón MC
    Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.